Skip to content

Revenue at other companies

HTF
Heartflow, Inc. Common StockHTFL
$52.59M+41.3%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
$666.95M-53.0%
DJT
Trump Media & Technology GroupDJT
$871.2K+6.1%
ADMA Biologics logo
ADMA BiologicsADMA
$114.49M-0.3%
Minerals Technologies logo
Minerals TechnologiesMTX
$546.9M+11.2%
Photronics logo
PhotronicsPLAB
$209.94M-0.5%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's revenue?
Haemonetics (HAE) reported revenue of $338.97M in Q4 2025.
How has Haemonetics's revenue changed year-over-year?
Haemonetics's revenue decreased by 2.7% year-over-year, from $348.54M to $338.97M.